Bausch Health to Announce Second Quarter 2025 Results on July 30
Bausch Health (NYSE:BHC) has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close. The company will host a conference call and live webcast at 5:00 p.m. EDT to discuss the results and provide a business update.
The presentation materials will be available on the company's Investor Relations website before the call, and a replay will be accessible afterward at ir.bauschhealth.com/events-and-presentations.
Bausch Health (NYSE:BHC) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025, dopo la chiusura del mercato. La società terrà una conference call e una diretta webcast alle 17:00 EDT per discutere i risultati e fornire un aggiornamento sull'attività .
Il materiale della presentazione sarà disponibile sul sito web delle Relazioni con gli Investitori prima della chiamata, e una registrazione sarà accessibile successivamente su ir.bauschhealth.com/events-and-presentations.
Bausch Health (NYSE:BHC) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025, después del cierre del mercado. La compañÃa realizará una llamada conferencia y una transmisión en vivo a las 5:00 p.m. EDT para discutir los resultados y proporcionar una actualización del negocio.
Los materiales de la presentación estarán disponibles en el sitio web de Relaciones con Inversores antes de la llamada, y una repetición estará accesible después en ir.bauschhealth.com/events-and-presentations.
Bausch Health (NYSE:BHC)ëŠ� 2025ë…� 2분기 재무실ì 발표ë¥� 2025ë…� 7ì›� 30ì� ìž� ë§ˆê° í›„ì— ì˜ˆì •í•˜ê³ ìžˆìŠµë‹ˆë‹¤. 회사ëŠ� 오후 5ì‹� EDTì—� 컨í¼ëŸ°ìФ 콜과 ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ë¥� 진행하여 실ì ì� ë…¼ì˜í•˜ê³ 사업 ì—…ë°ì´íЏë¥� ì œê³µí•� ì˜ˆì •ìž…ë‹ˆë‹�.
발표 ìžë£ŒëŠ� ì½� ì „ì— íšŒì‚¬ì� 투ìžìž� ê´€ê³� 웹사ì´íЏì—서 ì œê³µë˜ë©°, ì´í›„ ir.bauschhealth.com/events-and-presentationsì—서 다시 보기ë¡� ì´ìš©í•� ìˆ� 있습니다.
Bausch Health (NYSE:BHC) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 30 juillet 2025, après la clôture du marché. La société organisera une conférence téléphonique et une diffusion en direct à 17h00 EDT pour discuter des résultats et fournir une mise à jour commerciale.
Les documents de présentation seront disponibles sur le site des Relations Investisseurs avant l'appel, et un replay sera accessible ensuite sur ir.bauschhealth.com/events-and-presentations.
Bausch Health (NYSE:BHC) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 30. Juli 2025 nach Börsenschluss geplant. Das Unternehmen wird um 17:00 Uhr EDT eine Telefonkonferenz und eine Live-Webcast veranstalten, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben.
Die Präsentationsunterlagen werden vor dem Anruf auf der Investor-Relations-Website des Unternehmens verfügbar sein, und eine Aufzeichnung wird danach unter ir.bauschhealth.com/events-and-presentations abrufbar sein.
- None.
- None.
LAVAL, QC / / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, July 30, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit and connect with us on .
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original on ACCESS Newswire